Lipoprotein glycation and its metabolic consequences

被引:72
作者
Lyons, TJ
Jenkins, AJ
机构
[1] Medical University of South Carolina, Charleston, SC
[2] Div. Endocrinol., Diabet. Med. Gen., Medical University of South Carolina, Charleston, SC 29425
关键词
D O I
10.1097/00041433-199706000-00008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glycation of lipoproteins is implicated in the development of the macro- and microvascular complications of diabetes, atherosclerosis in general, and other disease processes including aging. Enhanced glycation may have direct effects, and may also amplify the effects of oxidative stress on lipoproteins, Most studies have examined the effects of glycation of LDL, particularly with respect to its atherogenicity, Other lipoproteins are more difficult to study because their several apolipoproteins, being of varying age, are not uniformly exposed to glucose. Inhibition of the combined stresses of glycation and oxidation towards lipoproteins may have beneficial effects an health.
引用
收藏
页码:174 / 180
页数:7
相关论文
共 69 条
[1]  
Azevedo M S, 1988, J Diabet Complications, V2, P19, DOI 10.1016/0891-6632(88)90021-9
[2]   ROLE OF OXIDATIVE STRESS IN DEVELOPMENT OF COMPLICATIONS IN DIABETES [J].
BAYNES, JW .
DIABETES, 1991, 40 (04) :405-412
[3]   AUTOANTIBODIES AGAINST OXIDATIVELY MODIFIED LOW-DENSITY LIPOPROTEINS IN NIDDM [J].
BELLOMO, G ;
MAGGI, E ;
POLI, M ;
AGOSTA, FG ;
BOLLATI, P ;
FINARDI, G .
DIABETES, 1995, 44 (01) :60-66
[4]   Non-insulin dependent diabetes and reverse cholesterol transport [J].
Berthezene, F .
ATHEROSCLEROSIS, 1996, 124 :S39-S42
[5]   GLYCOSYLATED LOW-DENSITY-LIPOPROTEIN IS MORE SENSITIVE TO OXIDATION - IMPLICATIONS FOR THE DIABETIC PATIENT [J].
BOWIE, A ;
OWENS, D ;
COLLINS, P ;
JOHNSON, A ;
TOMKIN, GH .
ATHEROSCLEROSIS, 1993, 102 (01) :63-67
[6]   NONENZYMATIC GLYCOSYLATION PRODUCTS ON COLLAGEN COVALENTLY TRAP LOW-DENSITY LIPOPROTEIN [J].
BROWNLEE, M ;
VLASSARA, H ;
CERAMI, A .
DIABETES, 1985, 34 (09) :938-941
[7]   LIPID ADVANCED GLYCOSYLATION - PATHWAY FOR LIPID OXIDATION IN-VIVO [J].
BUCALA, R ;
MAKITA, Z ;
KOSCHINSKY, T ;
CERAMI, A ;
VLASSARA, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) :6434-6438
[8]   IDENTIFICATION OF THE MAJOR SITE OF APOLIPOPROTEIN-B MODIFICATION BY ADVANCED GLYCOSYLATION END-PRODUCTS BLOCKING UPTAKE BY THE LOW-DENSITY-LIPOPROTEIN RECEPTOR [J].
BUCALA, R ;
MITCHELL, R ;
ARNOLD, K ;
INNERARITY, T ;
VLASSARA, H ;
CERAMI, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (18) :10828-10832
[9]   MODIFICATION OF LOW-DENSITY-LIPOPROTEIN BY ADVANCED GLYCATION END-PRODUCTS CONTRIBUTES TO THE DYSLIPIDEMIA OF DIABETES AND RENAL-INSUFFICIENCY [J].
BUCALA, R ;
MAKITA, Z ;
VEGA, G ;
GRUNDY, S ;
KOSCHINSKY, T ;
CERAMI, A ;
VLASSARA, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) :9441-9445
[10]  
CALVO C, 1993, EUR J CLIN CHEM CLIN, V31, P217